en: The U.S. Food and Drug Administration rejected ImClone 's original application in December 2001 , saying the trial had been sloppily conducted . The Food and Drug Administration ultimately denied ImClone 's drug application in December 2001 , saying that an Erbitux clinical trial was deficient .
ms: Pentadbiran Makanan dan Dadah A.S. menolak permohonan asal ImClone pada Disember 2001, dengan mengatakan bahawa percubaan itu telah dijalankan secara sloppily. Pentadbiran Makanan dan Dadah akhirnya menafikan permohonan ubat ImClone pada Disember 2001, mengatakan bahawa percubaan klinikal Erbitux kekurangan.